BRPI0714320A2 - Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica - Google Patents

Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica

Info

Publication number: BRPI0714320A2
Authority: BR; Brazil
Prior art keywords: imidazo; pyridine; preparation; therapeutic application; carboxamide derivative
Prior art date: 2006-07-03

Application number

BRPI0714320-6A2A

Other languages

English (en)

Inventor

Youssef El-Ahmad

Anne Olivier

Jean-Francois Peyronel

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-03

Filing date

2007-07-03

Publication date

2014-06-24

2007-07-03 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2014-06-24 Publication of BRPI0714320A2 publication Critical patent/BRPI0714320A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0714320-6A2A 2006-07-03 2007-07-03 Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica BRPI0714320A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0606012A FR2903107B1 (fr)	2006-07-03	2006-07-03	Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
PCT/FR2007/001125 WO2008003856A1 (fr)	2006-07-03	2007-07-03	Dérivés d'imidazo[1,2-a]pyridine-2-carboxamides leur préparation et leur application en thérapeutique

Publications (1)

Publication Number	Publication Date
BRPI0714320A2 true BRPI0714320A2 (pt)	2014-06-24

Family

ID=37775231

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0714320-6A2A BRPI0714320A2 (pt)	2006-07-03	2007-07-03	Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica

Country Status (24)

Country	Link
US (2)	US7704989B2 (pt)
EP (1)	EP2041133B1 (pt)
JP (1)	JP5259587B2 (pt)
KR (1)	KR20090024776A (pt)
CN (1)	CN101484453B (pt)
AT (1)	ATE484504T1 (pt)
AU (1)	AU2007271008B2 (pt)
BR (1)	BRPI0714320A2 (pt)
CA (1)	CA2655713C (pt)
CY (1)	CY1111868T1 (pt)
DE (1)	DE602007009839D1 (pt)
DK (1)	DK2041133T3 (pt)
ES (1)	ES2354482T3 (pt)
FR (1)	FR2903107B1 (pt)
HK (1)	HK1135964A1 (pt)
HR (1)	HRP20110015T1 (pt)
IL (1)	IL195891A0 (pt)
MX (1)	MX2008016546A (pt)
PL (1)	PL2041133T3 (pt)
PT (1)	PT2041133E (pt)
RS (1)	RS51652B (pt)
RU (1)	RU2441003C2 (pt)
SI (1)	SI2041133T1 (pt)
WO (1)	WO2008003856A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2903108B1 (fr) *	2006-07-03	2008-08-29	Sanofi Aventis Sa	Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.
ES2401557T3 (es)	2007-08-02	2013-04-22	Amgen, Inc	Moduladores de Pl3 cinasas y métodos de uso
JP5520831B2 (ja) *	2007-12-19	2014-06-11	アムジエン・インコーポレーテツド	Ｐｉ３キナーゼの阻害薬
FR2925905B1 (fr)	2008-01-02	2010-11-05	Sanofi Aventis	DERIVES DE 2-BENZOYL-IMIDAZO°1,2-a!PYRIDINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2925903B1 (fr)	2008-01-02	2011-01-21	Sanofi Aventis	DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2925901B1 (fr) *	2008-01-02	2011-03-04	Sanofi Aventis	DERIVES DE N-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2925900B1 (fr) *	2008-01-02	2011-03-04	Sanofi Aventis	DERIVES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2925906B1 (fr) *	2008-01-02	2010-08-20	Sanofi Aventis	COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2928921B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines, leur preparation et leur application en therapeutique
FR2928923B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
FR2928922B1 (fr) *	2008-03-21	2010-04-23	Sanofi Aventis	Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
FR2928924B1 (fr)	2008-03-21	2010-04-23	Sanofi Aventis	Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
FR2933609B1 (fr)	2008-07-10	2010-08-27	Fournier Lab Sa	Utilisation de derives d'indole comme activateurs de nurr-1, pour le traitement de la maladie de parkinson.
US8569512B2 (en)	2009-03-23	2013-10-29	Merck Sharp & Dohme Corp.	P2X3 receptor antagonists for treatment of pain
AU2010229142A1 (en)	2009-03-23	2011-10-13	Merck Sharp & Dohme Corp.	P2X3, receptor antagonists for treatment of pain
FR2950053B1 (fr)	2009-09-11	2014-08-01	Fournier Lab Sa	Utilisation de derives d'indole benzoique comme activateurs de nurr-1, pour le traitement de la maladie de parkinson
FR2955110A1 (fr)	2010-01-08	2011-07-15	Fournier Lab Sa	Nouveaux derives de type pyrrolopyridine benzoique
ES2573148T3 (es) *	2010-08-25	2016-06-06	Neopharm Co., Ltd.	Compuestos y composición de 1H-benzo[d]imidazol-5-ilo para el tratamiento de enfermedades inflamatorias
WO2014103801A1 (ja)	2012-12-28	2014-07-03	株式会社新日本科学	イミダゾピリジン誘導体を有効成分として含むｏｃｔ３活性阻害剤又はｏｃｔ３検出剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2638161B1 (fr) *	1988-10-24	1991-01-11	Centre Nat Rech Scient	Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
US6489337B1 (en)	2000-03-31	2002-12-03	Ortho-Mcneil Pharmaceutical, Inc.	Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo[1,2-a] pyridines
DE10117184A1 (de)	2001-04-05	2002-10-17	Gruenenthal Gmbh	Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
AU2002351412B2 (en)	2001-12-21	2010-05-20	Exelixis Patent Company Llc	Modulators of LXR
GB0303503D0 (en)	2003-02-14	2003-03-19	Novartis Ag	Organic compounds
WO2004089366A1 (en)	2003-04-10	2004-10-21	Pfizer Japan, Inc.	Bicyclic compounds as nr2b receptor antagonists
PE20050952A1 (es)	2003-09-24	2005-12-19	Novartis Ag	Derivados de isoquinolina como inhibidores de b-raf
US7868205B2 (en) *	2003-09-24	2011-01-11	Methylgene Inc.	Inhibitors of histone deacetylase
CA2543707A1 (en)	2003-10-31	2005-05-19	Takeda Pharmaceutical Company Limited	Nitrogen-containing fused heterocyclic compounds
US7767670B2 (en) *	2003-11-13	2010-08-03	Ambit Biosciences Corporation	Substituted 3-carboxamido isoxazoles as kinase modulators
NZ553087A (en) *	2004-08-31	2010-12-24	Astrazeneca Ab	Quinazolinone derivatives and their use as B-raf inhibitors
AR053992A1 (es) *	2004-12-22	2007-05-30	Astrazeneca Ab	Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
CN101128454A (zh) *	2004-12-22	2008-02-20	阿斯利康(瑞典)有限公司	用作抗癌药物的吡啶羧酰胺衍生物
FR2903108B1 (fr) *	2006-07-03	2008-08-29	Sanofi Aventis Sa	Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique.

2006
- 2006-07-03 FR FR0606012A patent/FR2903107B1/fr not_active Expired - Fee Related
2007
- 2007-07-03 MX MX2008016546A patent/MX2008016546A/es active IP Right Grant
- 2007-07-03 RS RS20110009A patent/RS51652B/en unknown
- 2007-07-03 JP JP2009517332A patent/JP5259587B2/ja not_active Expired - Fee Related
- 2007-07-03 ES ES07803833T patent/ES2354482T3/es active Active
- 2007-07-03 KR KR1020097000050A patent/KR20090024776A/ko not_active Application Discontinuation
- 2007-07-03 AT AT07803833T patent/ATE484504T1/de active
- 2007-07-03 PT PT07803833T patent/PT2041133E/pt unknown
- 2007-07-03 EP EP07803833A patent/EP2041133B1/fr active Active
- 2007-07-03 PL PL07803833T patent/PL2041133T3/pl unknown
- 2007-07-03 DE DE602007009839T patent/DE602007009839D1/de active Active
- 2007-07-03 SI SI200730465T patent/SI2041133T1/sl unknown
- 2007-07-03 WO PCT/FR2007/001125 patent/WO2008003856A1/fr active Application Filing
- 2007-07-03 AU AU2007271008A patent/AU2007271008B2/en not_active Ceased
- 2007-07-03 CA CA2655713A patent/CA2655713C/fr not_active Expired - Fee Related
- 2007-07-03 RU RU2009103307/04A patent/RU2441003C2/ru not_active IP Right Cessation
- 2007-07-03 DK DK07803833.8T patent/DK2041133T3/da active
- 2007-07-03 CN CN200780025234XA patent/CN101484453B/zh not_active Expired - Fee Related
- 2007-07-03 BR BRPI0714320-6A2A patent/BRPI0714320A2/pt not_active IP Right Cessation
2008
- 2008-12-11 IL IL195891A patent/IL195891A0/en unknown
- 2008-12-17 US US12/337,007 patent/US7704989B2/en not_active Expired - Fee Related
2010
- 2010-01-05 HK HK10100041.7A patent/HK1135964A1/xx not_active IP Right Cessation
- 2010-02-24 US US12/711,779 patent/US8404848B2/en not_active Expired - Fee Related
2011
- 2011-01-11 HR HR20110015T patent/HRP20110015T1/hr unknown
- 2011-01-12 CY CY20111100038T patent/CY1111868T1/el unknown

Also Published As

Publication number	Publication date
HRP20110015T1 (hr)	2011-02-28
AU2007271008A1 (en)	2008-01-10
EP2041133A1 (fr)	2009-04-01
CN101484453A (zh)	2009-07-15
CA2655713C (fr)	2015-05-05
DE602007009839D1 (de)	2010-11-25
CA2655713A1 (fr)	2008-01-10
CY1111868T1 (el)	2015-11-04
MX2008016546A (es)	2009-02-06
JP5259587B2 (ja)	2013-08-07
US20090149441A1 (en)	2009-06-11
KR20090024776A (ko)	2009-03-09
WO2008003856A1 (fr)	2008-01-10
US8404848B2 (en)	2013-03-26
JP2009541471A (ja)	2009-11-26
FR2903107B1 (fr)	2008-08-22
US7704989B2 (en)	2010-04-27
RU2441003C2 (ru)	2012-01-27
RS51652B (en)	2011-10-31
PL2041133T3 (pl)	2011-04-29
RU2009103307A (ru)	2010-08-10
EP2041133B1 (fr)	2010-10-13
AU2007271008B2 (en)	2012-10-11
ATE484504T1 (de)	2010-10-15
US20100168155A1 (en)	2010-07-01
CN101484453B (zh)	2012-07-04
DK2041133T3 (da)	2011-02-07
FR2903107A1 (fr)	2008-01-04
HK1135964A1 (en)	2010-06-18
PT2041133E (pt)	2011-01-10
SI2041133T1 (sl)	2011-02-28
IL195891A0 (en)	2009-09-01
ES2354482T3 (es)	2011-03-15

Publication	Publication Date	Title
BRPI0714320A2 (pt)	2014-06-24	Derivado de imidazo[1,2-a] piridina-2-carboxamidas, sua preparação e sua aplicação em terapêutica
UY31727A (es)	2009-11-10	Derivados polisustituidos de 2-aril-6-fenil-imidazo[1,2-a]piridinas, su preparación y su aplicación en terapéutica
IL195818A0 (en)	2009-09-01	Derivatives of 2-benzoyl-imidazopyridines, preparation ,method thereof and use of same in therapeutics
CY1109962T1 (el)	2014-09-10	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
DK1326613T3 (da)	2004-10-11	Anvendelse af substituerede imidazo[1,2-a] pyridin-, -pyrimidin- og -pyrazin-3-yl-amin-derivater til fremstilling af lægemidler til NOS-inhibering
CY1109366T1 (el)	2014-07-02	Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
EP2650293A8 (en)	2013-12-25	[1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof
MX2009010165A (es)	2009-10-12	Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
ECSP067111A (es)	2007-01-26	Derivados de pirido-pirimidina, su preparación, su aplicación en terapéutica
MXPA06000231A (es)	2006-04-11	Derivados espiro '1-azabiciclo'2.2.2!octan-3,5'-oxazolidin-2'-ona! con afinidad a la alfa7 del receptor nicotinico para acetilcolina.
PL1869038T3 (pl)	2009-12-31	Podstawione pochodne 5,6,7,8-tetrahydro-imidazo[1,2-a]pirydyn-2-yloaminy i ich zastosowanie do wytwarzania środków leczniczych
UY31588A1 (es)	2009-08-03	Derivados de imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica
UY31587A1 (es)	2009-08-03	Derivados de n-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su aplicacion en terapéutica.
UY31592A1 (es)	2009-08-03	Compuestos de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica
UY32894A (es)	2011-04-29	Derivados de 5-fenil-pirazolopiridina, su preparación y su aplicación en terapéutica
UY31586A1 (es)	2009-08-03	Derivados de n-fenil-imidazo[1,2-a]piridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica
ATE555112T1 (de)	2012-05-15	Imidazoä4,5-büpyridin-2-onderivate und analoga davon als verbindungen für die krebstherapie
UY31590A1 (es)	2009-08-03	Derivados de n-heterociclico-6-heterociclico-imidazo[1,2-a]piridina-2-carboxamidas, su preparacion y su plicacion en terapéutica
UY31593A1 (es)	2009-08-03	Derivados de 2-heteroaroil-imidazo[1,2-a]piridina, su preparacion y su aplicacion en terapéutica
UY31591A1 (es)	2009-08-03	Derivados de 2-benzoil-imidazo[1,2-a]piridina, su preparacion y su aplicacion en terapéutica

Legal Events

Date	Code	Title	Description
2018-03-27	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-24	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2019-04-30	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 12A ANUIDADE.
2019-08-20	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2521 DE 30/04/2019.